PL438609A1 - Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych - Google Patents

Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych

Info

Publication number
PL438609A1
PL438609A1 PL438609A PL43860921A PL438609A1 PL 438609 A1 PL438609 A1 PL 438609A1 PL 438609 A PL438609 A PL 438609A PL 43860921 A PL43860921 A PL 43860921A PL 438609 A1 PL438609 A1 PL 438609A1
Authority
PL
Poland
Prior art keywords
mixture
extracts
composition containing
probiotics
vitis vinifera
Prior art date
Application number
PL438609A
Other languages
English (en)
Inventor
David Gaudout
Stéphane REY
Benoît LEMAIRE
Séverine DUBREUIL
Camille POUCHIEU
Original Assignee
Activ'inside
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activ'inside filed Critical Activ'inside
Publication of PL438609A1 publication Critical patent/PL438609A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Niniejszy wynalazek dotyczy kompozycji odżywczej lub farmaceutycznej zawierającej co najmniej jedną mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz co najmniej jedną bakterię probiotyczną i/lub drożdże probiotyczne. Taka kompozycja jest przeznaczona do stosowania jako produkt odżywczy lub lek w celu poprawy funkcji poznawczych u ludzi lub zwierząt.
PL438609A 2020-07-24 2021-07-26 Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych PL438609A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR2007796A FR3112686B3 (fr) 2020-07-24 2020-07-24 Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives

Publications (1)

Publication Number Publication Date
PL438609A1 true PL438609A1 (pl) 2022-01-31

Family

ID=78032387

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438609A PL438609A1 (pl) 2020-07-24 2021-07-26 Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych

Country Status (5)

Country Link
AU (1) AU2021107611A4 (pl)
DK (1) DK202100060U3 (pl)
FR (1) FR3112686B3 (pl)
PL (1) PL438609A1 (pl)
WO (1) WO2022018281A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3132221A1 (fr) * 2022-01-28 2023-08-04 Activ'inside Utilisation d’un mélange de flavanols pour augmenter la concentration de la forme active de la vitamine D, le calcitriol.
CN115300532B (zh) * 2022-09-20 2023-10-20 中加健康工程研究院(合肥)有限公司 具改善阿尔兹海默病认知能力的益生菌剂及其制备方法
FR3146578A1 (fr) * 2023-03-14 2024-09-20 Laboratoire D'innovation Cosmetique Et Dermatologique Nouvelle association à base de probiotiques, compositions la contenant et ses utilisations
WO2026020097A1 (en) * 2024-07-19 2026-01-22 Postbiotics Plus Research Llc Postbiotic compositions and methods of preparation and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899768B1 (fr) * 2006-04-14 2008-06-20 Juva Sante Soc Par Actions Sim Complement alimentaire antioxydant contenant des oligoproanthocyanides, du gamma-tocopherol, des catechines et biflavanes, de l'acide carnosique et du carnosol
EP2710901A1 (en) * 2012-09-20 2014-03-26 Symrise AG Dietary supplement compositions
BR112018008453A2 (pt) * 2015-10-27 2018-11-06 Activinside composição antioxidante sinergicamente eficaz para animais de estimação
FR3042712B1 (fr) * 2015-10-27 2019-05-03 Activ'inside Agent nutritionnel ou therapeutique particulier comprenant un melange de raisin et de bleuet
WO2017155898A1 (en) * 2016-03-07 2017-09-14 Nature's Sunshine Products, Inc. Methods and compositions to improve weight loss and cardiometabolic health beyond diet and exercise
CN107334025A (zh) * 2017-08-08 2017-11-10 安徽永骏生物科技有限公司 一种蓝莓发酵饮料
FR3088540B1 (fr) * 2018-11-21 2023-05-12 Activinside UTILISATION EN PRISE UNIQUE D’UNE COMPOSITION comprenant un melange PARTICULIER D’EXTRAIT DE RAISINS ET D’EXTRAIT DE BLEUETS

Also Published As

Publication number Publication date
AU2021107611A4 (en) 2022-01-06
FR3112686A3 (fr) 2022-01-28
FR3112686B3 (fr) 2022-07-29
WO2022018281A3 (fr) 2022-03-10
WO2022018281A2 (fr) 2022-01-27
DK202100060U3 (da) 2021-10-26

Similar Documents

Publication Publication Date Title
WO2022018281A3 (fr) Composition comprenant un melange d'extraits de vitis vinifera et de vaccinium angustifolium et des probiotiques pour ameliorer les fonctions cognitives
ur Rahman et al. In vivo effects of Allium cepa L. on the selected gut microflora and intestinal histomorphology in broiler
MX2021009398A (es) Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso.
RU2010126327A (ru) Композиция на основе пробиотических бактерий совместно с пребиотиком и ее применение в предупреждении и/или лечении респираторных патологий и/или инфекций и для улучшения функций кишечника
KR20000070973A (ko) 헬리코박터 에스피 감염의 예방 및 치료에 사용되는 경구용제제
Bortoluzzi et al. Effect of hops β-acids (Humulus lupulus) on performance and intestinal health of broiler chickens
MX2019005343A (es) Composiciones nutricionales que proporcionan manejo dietetico de colicos.
Heidari Soureshjani et al. Evaluation of antibacterial effect of sesame oil, olive oil and their synergism on Staphylococcus aureus in vitro
Zhu et al. Fish oil enhances intestinal barrier function and inhibits corticotropin-releasing hormone/corticotropin-releasing hormone receptor 1 signalling pathway in weaned pigs after lipopolysaccharide challenge
Chiancone et al. The use of a combination of Vaccinium macracarpon, Lycium barbarum L. and probiotics (Bifiprost®) for the prevention of chronic bacterial prostatitis: a double-blind randomized study
CL2019001938A1 (es) Composiciones probióticas y usos de las mismas.
MX2024005028A (es) Metodos y composiciones para proporcionar un beneficio para la salud en un animal.
FR3120188B3 (fr) Composition comprenant un extrait deVitis vinifera, de la vitamine C et des probiotiques pour lutter contre le vieillissement de la peau
WO2020165057A8 (en) Compositions containing bacillaene producing bacteria or preparations thereof
DE602004032502D1 (de) Behandlung von Krebs mit natürlichen Pflanzenprodukten, etherischen Ölen oder Inhaltsstoffen von Pistazia Arten
WO2021159068A8 (en) Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
PL414701A1 (pl) Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
MX2024006844A (es) Cepa de bacillus coagulans, composiciones de la misma y metodos de uso.
PL433015A1 (pl) Formulacja zawierającego kurkuminoidy ekstraktu z kurkumy sposób jej otrzymywania, napój koncentrat napoju, suplement diety, kompozycja farmaceutyczna zawierająca formulację oraz zastosowanie formulacji suplementach diety i produktach farmaceutycznych aktywujących metabolizm aldehydu octowego
PE20210319A1 (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas
BR112022025078A2 (pt) Agentes de aperfeiçoamento e de manutenção da função cognitiva e da função do hipocampo, alimentos ou bebidas de aperfeiçoamento e de manutenção da função cognitiva e da função do hipocampo, e, uso de uma ou ambas de bifidobacterium breve ferm bp-11175 e uma cultura de bifidobacterium breve ferm bp-11175
Swaggerty et al. Oregano essential oil: a pre-harvest tool to reduce Salmonella enterica serovar Enteritidis in market-age broilers
PL422140A1 (pl) Zastosowanie totarolu i kompozycja farmaceutyczna zawierająca totarol
PL438421A1 (pl) Zastosowanie kannabinoidów jako przeciwutleniaczy pełniących funkcje czynników pozwalających na utrzymanie odpowiedniej jakości i właściwości produktów spożywczych (żywności), produktów leczniczych, wyrobów medycznych i kosmetyków.
PL437487A1 (pl) Kompozycja farmaceutyczna oraz jej przeciwwirusowe zastosowanie